Mammoth Biosciences
Jason Lin is an Associate Scientist at Mammoth Biosciences, where research focuses on gene editing and biotechnology since August 2022. Previously, Jason served as a Senior Research Associate and a Masters Student at the University of California, Davis, contributing to AAV transduction projects from October 2019 to August 2022. Prior roles include Research Junior Specialist and Undergraduate Research Assistant at UC Davis, as well as coaching at the UC Davis Baseball Camp. Jason has also volunteered at UC Davis Medical Center and worked as a Community Organizer for Groundworks campaigns. Early experience includes a sales associate position at Levi Strauss & Co. Jason Lin holds a Master of Science in Animal Biology and a Bachelor of Applied Science in Neurobiology, Physiology, and Behavior from the University of California, Davis.
Mammoth Biosciences
3 followers
Mammoth Biosciences is harnessing the diversity of nature to power the next-generation of CRISPR products. Through the discovery and development of novel CRISPR systems, the company is enabling the full potential of its platform to improve lives by reading and writing the code of life. Mammoth aims to democratize disease detection with an easy and affordable point-of-care test that allows real-time and simultaneous detection of multiple conditions. By leveraging its internal research and development and exclusive licensing to Cas12, Cas13, Cas14, and CasΦ, Mammoth can provide enhanced diagnostics and genome editing for life science research, healthcare, agriculture, biodefense and more. Based in San Francisco, Mammoth Biosciences is co-founded by CRISPR pioneer Jennifer Doudna and principal founders Trevor Martin, Janice Chen, and Lucas Harrington. The firm is backed by top institutional investors including Mayfield, NFX, and 8VC, Decheng and leading individual investors including Brook Byers, Tim Cook, and Jeff Huber.